α-Enolase: a promising therapeutic and diagnostic tumor target
- PMID: 21261815
- DOI: 10.1111/j.1742-4658.2011.08025.x
α-Enolase: a promising therapeutic and diagnostic tumor target
Abstract
α-enolase (ENOA) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and thus mediates activation of plasmin and extracellular matrix degradation. In tumor cells, ΕΝΟΑ is upregulated and supports anaerobic proliferation (Warburg effect), it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. Both ENOA overexpression and its post-translational modifications could be of diagnostic and prognostic value in cancer. This review will discuss recent information on the biochemical, proteomics and immunological characterization of ENOA, particularly its ability to trigger a specific humoral and cellular immune response. In our opinion, this information can pave the way for effective new therapeutic and diagnostic strategies to counteract the growth of the most aggressive human disease.
© 2011 The Authors Journal compilation © 2011 FEBS.
Similar articles
-
Alpha-Enolase (ENO1), a potential target in novel immunotherapies.Front Biosci (Landmark Ed). 2017 Jan 1;22(5):944-959. doi: 10.2741/4526. Front Biosci (Landmark Ed). 2017. PMID: 27814656 Review.
-
Mass spectrometry analysis of the post-translational modifications of alpha-enolase from pancreatic ductal adenocarcinoma cells.J Proteome Res. 2010 Jun 4;9(6):2929-36. doi: 10.1021/pr901109w. J Proteome Res. 2010. PMID: 20433201
-
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.J Proteome Res. 2011 Jan 7;10(1):105-12. doi: 10.1021/pr100213b. Epub 2010 Jun 10. J Proteome Res. 2011. PMID: 20455595
-
Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target.PLoS One. 2013 Jul 19;8(7):e69354. doi: 10.1371/journal.pone.0069354. Print 2013. PLoS One. 2013. PMID: 23894455 Free PMC article.
-
α-Enolase, a multifunctional protein: its role on pathophysiological situations.J Biomed Biotechnol. 2012;2012:156795. doi: 10.1155/2012/156795. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118496 Free PMC article. Review.
Cited by
-
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions.Cancer Immunol Immunother. 2013 Jul;62(7):1249-60. doi: 10.1007/s00262-013-1429-3. Epub 2013 May 3. Cancer Immunol Immunother. 2013. PMID: 23640603 Free PMC article.
-
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.Haematologica. 2013 Jan;98(1):71-8. doi: 10.3324/haematol.2012.066555. Epub 2012 Jun 24. Haematologica. 2013. PMID: 22733020 Free PMC article. Clinical Trial.
-
Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variants.PLoS One. 2015 Apr 13;10(4):e0122994. doi: 10.1371/journal.pone.0122994. eCollection 2015. PLoS One. 2015. PMID: 25874870 Free PMC article.
-
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.J Hematol Oncol. 2015 Mar 8;8:22. doi: 10.1186/s13045-015-0117-5. J Hematol Oncol. 2015. PMID: 25887760 Free PMC article.
-
Three are better than one: plasminogen receptors as cancer theranostic targets.Exp Hematol Oncol. 2013 Apr 17;2(1):12. doi: 10.1186/2162-3619-2-12. Exp Hematol Oncol. 2013. PMID: 23594883 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources